Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05317585 · ClinicalTrials.gov registry record · NA
Continuous Glucose Monitor Use in Pregnancy
A NA study of Pregnancy, High Risk and Type 2 Diabetes Treated With Insulin, sponsored by University of Massachusetts, Worcester.
- Recruiting
- Registry status
- NA
- Development phase
- 180
- Enrollment target
- 1
- Study location
NCT05317585: Recruiting NA study of Pregnancy, High Risk and Type 2 Diabetes Treated With Insulin, sponsored by University of Massachusetts, Worcester.
NCT05317585 is a NA study of Pregnancy, High Risk and Type 2 Diabetes Treated With Insulin that is actively recruiting participants, run by University of Massachusetts, Worcester. The registered enrollment target is 180 participants, below the 308-participant average among 20 other Pregnancy, High Risk trials with a reported enrollment target (42% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05317585, a NA study of Pregnancy, High Risk and Type 2 Diabetes Treated With Insulin, is actively recruiting participants, sponsored by University of Massachusetts, Worcester.
- RECRUITING
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to perform a randomized controlled trial among 180 pregnant women with type 2 diabetes mellitus (T2DM) comparing continuous glucose monitor (CGM) use to the standard of care of multiple daily fingerstick glucose monitoring and its impact on large for gestational age infants, maternal glycemic control, patient satisfaction, and additional adverse perinatal outcomes.
Primary Outcome
The neonatal birthweight will be used to calculate large for gestational age size based on the gestational age at delivery.
Conditions Studied
Interventions
- DEVICE Continuous Glucose Monitor
- DEVICE Routine Capillary Blood Glucose Monitoring (Fingerstick Glucose)
Study Locations (1)
Massachusetts
- University of Massachusetts Memorial Medical Center - Worcester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2024-05-23 |
| Est. Completion | 2027-07-01 |
| Phase | NA |
What NCT05317585 shows while recruiting
NCT05317585 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 308-participant average among 20 other Pregnancy, High Risk trials with a reported enrollment target (42% lower).
The record links to 2 conditions, with Pregnancy, High Risk appearing as the primary indexed condition, and to 2 interventions - of which Continuous Glucose Monitor is the first listed.
NCT05317585 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05317585 about?
NCT05317585 is a clinical study titled "Continuous Glucose Monitor Use in Pregnancy". The purpose of this study is to perform a randomized controlled trial among 180 pregnant women with type 2 diabetes mellitus (T2DM) comparing continuous glucose monitor (CGM) use to the standard of care of multiple daily fingerstick glucose monitoring and its impact on large for gestational age infa...
What is the current status of trial NCT05317585?
This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2024-05-23. Estimated completion is 2027-07-01.
What conditions does trial NCT05317585 study?
This clinical trial studies the following conditions: Pregnancy, High Risk, Type 2 Diabetes Treated With Insulin.
What interventions are being tested in trial NCT05317585?
The interventions under investigation include: Continuous Glucose Monitor (DEVICE), Routine Capillary Blood Glucose Monitoring (Fingerstick Glucose) (DEVICE).
Who is sponsoring clinical trial NCT05317585?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05317585 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy, High Risk
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05317585's enrollment target sits among peer trials
180 7th of 20 higher than 14 of 20 other Pregnancy, High Risk trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy, High Risk trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Successfully Achieving and Maintaining Euglycemia During Pregnancy for Type 2 Diabetes Through Technology and Coaching
RECRUITING · NA
-
Early Detection of Gestational Diabetes Mellitus in Pregnancy
RECRUITING · NA
-
A Randomized Controlled Trial of Diabetes Screening Immediately Postpartum (DIP) and Follow Up PP CARE
RECRUITING · NA
-
Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes
RECRUITING · NA
-
Daily Meditation Program in Women Admitted to the Antepartum Unit
COMPLETED · NA
-
A Randomized Placebo Controlled Pilot Study of Probiotic Supplementation in At-risk Pregnant Women
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI